Showing results (111-120 of 155) with videos related to

Sort By:
Pageof 16
Arthritis Care & Research|March 23, 2012
Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhoodArnd Heiligenhaus, Ivan Foeldvari, Clive Edelsten, et al.
Archives of Disease in Childhood|August 15, 2018
Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015Robert M R Tulloh, Richard Mayon-White, Anthony Harnden, et al.
Lancet (London, England)|January 25, 2025
Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trialNisha R Acharya, Athimalaipet V Ramanan, Alison B Coyne, et al.
Health Technology Assessment (Winchester, England)|August 8, 2020
Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility studyAshley P Jones, Dannii Clayton, Gloria Nkhoma, et al.
Ophthalmology|January 10, 2018
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) InitiativeAndrew D Dick, James T Rosenbaum, Hassan A Al-Dhibi, et al.
Rheumatology (Oxford, England)|September 11, 2024
Clinical spectrum of and outcomes for Indian children with deficiency of adenosine deaminase 2 (DADA2): a multicentric studySathish Kumar, Akagri Chugh, Samantha Cheryl Kumar, et al.
Trials|February 18, 2026
Moving towards optimized treatment for children and adolescents with juvenile idiopathic arthritis in sustained remission randomized to continue stable treatment, methotrexate withdrawal or tumor necrosis factor inhibitor withdrawal: study protocol for the Norwegian multi-center MOVE-JIA trialSiri Opsahl Hetlevik, Vibke Lilleby, Maiju Pesonen, et al.
Rheumatology (Oxford, England)|December 17, 2020
The management of Sjögren's syndrome: British Society for Rheumatology guideline scopeElizabeth Price, Alexander Allen, Saaeha Rauz, et al.
The Lancet. Respiratory Medicine|March 7, 2021
Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trialArvinder S Soin, Kuldeep Kumar, Narendra S Choudhary, et al.
Pediatric Rheumatology Online Journal|May 19, 2025
Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitisAthimalaipet V Ramanan, Andrew D Dick, Thomas Jaki, et al.
Pageof 16